

NDDS/Formulation Development | Product Development | Technology Transfer | Business Development | Portfolio Management | New Lab Set up | Manufacturing | Project Management A versatile, high-energy professional with the distinction of developing formulation for USFDA and Europe Market within strict time schedules, cost & quality
· To develop pharmaceutical products equivalent to innovator products.
· Provide inputs for analytical method development for product and review data from analytical tests and recommends shelf-life and packaging requirements.
· To prepare and review of Stability Protocols & Reports.
· To review documents like protocols and those relating to development, validation, manufacturing and packaging, like validation protocols, Master formula and their corresponding reports and to give suitable comments/ suggestions on same.
· To supervise manufacture of developed products and process validation of same.
· To review development trials logbooks, LNB’s etc.
· To prepare project proposals, project planning for all new projects.
· To prepare detailed project planning for all projects and to ensure that plan is adhered to. To ensure that all projects’ milestones are completed as per the agreed planning.
To track the progress of projects and report to the Director- R&D in case of any deviations.
• Pre-formulation Studies.
• Development of new formulations.
• Pilot plant scale-up.
• Excipient’s compatibility study
• Transfer of technology to manufacturing units.
• Trouble shooting at production floor.
• Documentation pertaining to developmental activities.
• Development report preparations.
Pharmaceutical Research and Development
Generic product development
Innovative product development
Drug Discovery
Program Mangment
Team Leader
Oncology product development
ü 18 Successful Bioequivalence product developed.
ü 2 molecules identified for 505 (b)(2) for different indications and filed the patent for proof of concept.
ü Additionally handling business development responsibility and successfully signed licensing and supply deal around 4 million dollars in 2 years. On product approvals, expected business around 6-7 million dollars on every year.
ü New markets business established in USA, Greece, Germany, UK, Spain, Brazil, Chile, Peru, GCC countries under finished product license and supply model
ü Successfully set up the new R&D Centre for general solid and liquid orals.
ü Successfully set up new R&D Centre for Oncology and potent block for solid and liquid orals.
· Involved new R&D lab set up as per requirement of European agencies.
· Successfully cleared European agency audit in 2012 and 2014.
· Successfully executed expansion / modification / upgradation projects such as installation of new equipment for production activity, new warehouse facility with HVAC and sampling & dispensing booth.
· Two times performance of the year awards winner